Cardiology Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The rationale and design of the FORωARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation
American Heart Journal, 01/12/09

Macchia A et al. - The Fish Oil Reserach with ω-3 for Atrial fibrillation Recurrence Delay (FORωARD) trial will determine whether pharmacologic supplementation with 1 g of ω-3–acid ethyl esters can reduce AF recurrence in patients with previous AF who have recovered normal sinus rhythm.

<< Previous
Clinical and arrhythmic outcomes after implantation of a...

Next >>
Coffee consumption and mortality after acute myocardial...